European Commission grants orphan drug designation to Alligator Bioscience’s HLX22 to treat gastric cancer: Lund, Sweden Tuesday, May 27, 2025, 18:00 Hrs [IST] Alligator Bioscie ...

LUND, SE / ACCESS Newswire / May 26, 2025 / Alligator Bioscience (STO:ATORX) - Lund, Sweden - 26 May 2025 - Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that the European Commission ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Nasopharyngeal Cancer Pipeline ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "Bevacizumab - Biosimilar Insight, 2025" has been added to ResearchAndMarkets.com's offering. Bevacizumab - Biosimilar Insight, 2025 offers an in-depth ...

The Hyderabad-based company highlighted that it had launched seven new products in the US market in the fourth quarter of FY 25 and it included a partnership with Shanghai Henlius Biotech ...

During the quarter, Dr Reddy’s partnered with Shanghai Henlius Biotech, Inc. to commercialise HLX15 (daratumumab biosimilar) in the U.S. and Europe. It also teamed up with Bio-Thera Solutions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...